Literature DB >> 3131281

The induction of bladder tumors in F344 rats by intravesicular administration of some nitrosamines.

B J Thomas1, R M Kovatch, W Lijinsky.   

Abstract

Three nitrosamines, metabolically related and formed in vivo from the bladder carcinogen nitrosomethyl-n-octylamine, were administered to groups of 12 female F344 rats by intraurethral instillation twice a week for 30 weeks. All three compounds induced tumors in the urinary bladder. Nitrosomethyl-2-oxopropylamine at 10 mg/ml was the most potent, causing death of half of the animals with tumors at 43 weeks, following a total dose of 1.0 mmol; most of the rats also had tumors of the nasal mucosa, and there were some tumors of the kidney and kidney pelvis. Nitrosomethyl-2-hydroxypropylamine at 10 mg/ml (total dose 1.0 mmol) was much less effective, the median week of death being 83 weeks. In addition to bladder tumors, this group had tumors of the nasal mucosa, esophagus, and kidney. Nitrosomethyl-3-carboxypropylamine at 75 mg/ml and a total dose of 6.2 mmol per rat induced a high incidence of bladder tumors and tumors of the kidney pelvis, but not tumors of the nasal mucosa; the median week of death for this group was 55 weeks. It is concluded that nitrosomethyl-n-alkylamines that induce bladder tumors by oral administration to rats are metabolized to nitrosomethyl-3-carboxypropylamine, which is excreted in the urine and further metabolized to nitrosomethyl-2-oxopropylamine, the proximate bladder carcinogen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131281      PMCID: PMC5917489          DOI: 10.1111/j.1349-7006.1988.tb01592.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  11 in total

1.  [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].

Authors:  H Druckrey; R Preussmann; S Ivankovic; D Schmähl
Journal:  Z Krebsforsch       Date:  1967

Review 2.  Structure-activity relations in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Carcinogenesis in F344 rats by N-nitrosomethyl-n-propylamine derivatives.

Authors:  W Lijinsky; M D Reuber; J E Saavedra; G M Singer
Journal:  J Natl Cancer Inst       Date:  1983-05       Impact factor: 13.506

4.  Induction of urinary bladder tumors by intravesicular instillation of butyl(4-hydroxybutyl)nitrosoamine and its principal urinary metabolite, butyl(3-carboxypropyl)nitrosoamine in rats.

Authors:  Y Hashimoto; K Suzuki; M Okada
Journal:  Gan       Date:  1974-02

5.  Carcinogenesis in rats by nitrosodimethylamine and other nitrosomethylalkylamines at low doses.

Authors:  W Lijinsky; M D Reuber
Journal:  Cancer Lett       Date:  1984-02       Impact factor: 8.679

6.  Carcinogenesis in Fischer rats by nitrosodipropylamine, nitrosodibutylamine and nitrosobis(2-oxopropyl)amine given by gavage.

Authors:  W Lijinsky; M D Reuber
Journal:  Cancer Lett       Date:  1983-06       Impact factor: 8.679

7.  Urinary bladder neoplasms in Syrian hamsters after administration of N-nitroso-N-methyl-N-dodecylamine.

Authors:  J Althoff; W Lijinsky
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-12-15

8.  Dose response studies of carcinogenesis in rats by nitrosodiethylamine.

Authors:  W Lijinsky; M D Reuber; C W Riggs
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

9.  Relationship of rat urinary metabolites of N-nitrosomethyl-N-alkylamine to bladder carcinogenesis.

Authors:  G M Singer; W Lijinsky; L Buettner; G A McClusky
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

10.  Induction of carcinogenesis in Fischer rats by methylalkylnitrosamines.

Authors:  W Lijinsky; J E Saavedra; M D Reuber
Journal:  Cancer Res       Date:  1981-04       Impact factor: 12.701

View more
  1 in total

1.  Local and systemic carcinogenic effects of alkylating carcinogens in rats treated by intravesicular administration.

Authors:  W Lijinsky; B J Thomas; R M Kovatch
Journal:  Jpn J Cancer Res       Date:  1991-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.